May 21, 2021Open Access

Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking

Key Points

Key points are not available for this paper at this time.

Abstract

Our findings provide an essential role and basis for further immune-inflammatory studies into the molecular mechanisms of WP and TNFis development in RA.

Read Full Paperexternally

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Bai et al. (Fri,) studied this question.

synapsesocial.com/papers/6a045c8d80279b92487e70c6 https://doi.org/https://doi.org/10.3389/fphar.2021.690118

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis2000 · 375 citations
2A new phenolic glycoside from Paeonia lactiflora2006 · 13 citations
3098 Use of Disease-Modifying Therapies and Glucocorticoids in the Early Treatment of Rheumatoid Arthritis: Observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis2016 · 2 citations
4Selective Blockade of Tumor Necrosis Factor Receptor I Inhibits Proinflammatory Cytokine and Chemokine Production in Human Rheumatoid Arthritis Synovial Membrane Cell Cultures2013 · 37 citations
5Protective effect of betulinic acid on Freund's complete adjuvant‐induced arthritis in rats2019 · 17 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper